Bolt Biotherapeutics, Inc. Common Stock (BOLT) is a publicly traded Healthcare sector company. As of October 23, 2026, BOLT trades at $4.03 with a market cap of $7.98M and a P/E ratio of -0.21. BOLT moved -3.79% today. Year to date, BOLT is -25.97%; over the trailing twelve months it is -25.31%. Its 52-week range spans $3.10 to $9.66. Analyst consensus is neutral with an average price target of $0.00. Rallies surfaces BOLT's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Rallies tracks the latest BOLT news, catalysts, market updates, source links, and AI summaries when news is available.
| Metric | Value |
|---|---|
| Price | $4.03 |
| Market Cap | $7.98M |
| P/E Ratio | -0.21 |
| EPS | $-16.51 |
| Dividend Yield | 0.00% |
| 52-Week High | $9.66 |
| 52-Week Low | $3.10 |
| Volume | 0 |
| Avg Volume | 0 |
| Revenue (TTM) | $4.70M |
| Net Income | $-28.74M |
| Gross Margin | 0.00% |
1 analysts cover BOLT: 0 strong buy, 0 buy, 1 hold, 0 sell, 0 strong sell. Consensus rating is neutral. Average price target: $0.00.